Skip to main content
HR 5773 115th Congress House Health Administrative law and regulatory procedures Department of Health and Human Services Drug therapy Drug trafficking and controlled substances Drug, alcohol, tobacco use Fraud offenses and financial crimes Government information and archives Health care costs and insurance Health information and medical records Medicare Prescription drugs Public contracts and procurement Right of privacy

PASS Act of 2018

Introduced: May 11, 2018 See on congress.gov
 Everywhere this bill has been 14 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 20, 2018
Received in the Senate and Read twice and referred to the Committee on Finance.
Jun 19, 2018
The title of the measure was amended. Agreed to without objection.
Jun 19, 2018
Motion to reconsider laid on the table Agreed to without objection.
Jun 19, 2018
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5258-5259)
Jun 19, 2018
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5258-5259)
Jun 19, 2018
DEBATE - The House proceeded with forty minutes of debate on H.R. 5773.
Jun 19, 2018
Considered under suspension of the rules. (consideration: CR H5258-5261)
Jun 19, 2018
Mr. Roskam moved to suspend the rules and pass the bill, as amended.
Jun 19, 2018
Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-761, Part I.
Jun 4, 2018
Referred to the Subcommittee on Health.
May 16, 2018
Ordered to be Reported (Amended) by Voice Vote.
May 16, 2018
Committee Consideration and Mark-up Session Held.
May 11, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 11, 2018
Introduced in House
 Plain-English summary Congressional Research Service

Preventing Addiction for Susceptible Seniors Act of 2018 or the PASS Act of 2018

(Sec. 2) This bill alters several requirements under the Medicare prescription drug benefit. Specifically, the bill requires electronic prescription programs to enable the secure transmittal of prior authorization requests for covered drugs.

(Sec. 3) The bill also requires the Centers for Medicare & Medicaid Services (CMS) to establish a secure online portal to allow: (1) data sharing among the CMS, Medicare prescription drug benefit plans, and Medicare Advantage (MA) plans; and (2) referrals by such plans of substantiated fraud, waste, or abuse in order to initiate or assist investigations by contracted entities under the Medicare Integrity Program.

(Sec. 4) The bill also establishes individuals who are identified as at-risk beneficiaries for prescription drug abuse as qualifying participants in medication therapy management programs under the Medicare prescription drug benefit.

(Sec. 5) The CMS must also: (1) identify outlier prescribers of opioids under Medicare prescription drug benefit plans and MA plans, based on specialty and geographic area; and (2) annually notify such prescribers of their status and provide them with resources on proper prescribing methods.

What's happening now June 20, 2018

Received in the Senate and Read twice and referred to the Committee on Finance.

 Committees of jurisdiction 4